These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 27344157)

  • 41. Clinical implications of six inflammatory biomarkers as prognostic indicators in Ewing sarcoma.
    Li YJ; Yang X; Zhang WB; Yi C; Wang F; Li P
    Cancer Manag Res; 2017; 9():443-451. PubMed ID: 29033609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prognostic value of C-reactive protein/albumin ratio in nasopharyngeal carcinoma: a meta-analysis.
    Gao N; Yang RN; Meng Z; Wang WH
    Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30352836
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer.
    Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Shibuya N; Kubota K
    Ann Surg Oncol; 2016 Mar; 23(3):900-7. PubMed ID: 26530445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preoperative C-reactive protein to albumin ratio is a predictor of survival after pancreatic resection for pancreatic ductal adenocarcinoma.
    Ikuta S; Aihara T; Yamanaka N
    Asia Pac J Clin Oncol; 2019 Oct; 15(5):e109-e114. PubMed ID: 30632282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy.
    Linton A; Pond G; Clarke S; Vardy J; Galsky M; Sonpavde G
    Clin Genitourin Cancer; 2013 Dec; 11(4):423-30. PubMed ID: 23816526
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Can C-reactive protein-based biomarkers be used as predictive of 30-day mortality in elderly hip fractures?A retrospective study.
    Balta O; Altınayak H; Gürler Balta M; Astan S; Uçar C; Kurnaz R; Zengin EC; Eren MB
    Ulus Travma Acil Cerrahi Derg; 2022 Jun; 28(6):849-856. PubMed ID: 35652864
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of Modified Glasgow Prognostic Score for Pancreatic Cancer: A Retrospective Cohort Study.
    Imaoka H; Mizuno N; Hara K; Hijioka S; Tajika M; Tanaka T; Ishihara M; Yogi T; Tsutsumi H; Fujiyoshi T; Sato T; Shimizu Y; Niwa Y; Yamao K
    Pancreas; 2016 Feb; 45(2):211-7. PubMed ID: 26495775
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The C-Reactive Protein/Albumin Ratio Is Useful for Predicting Short-Term Survival in Cancer and Noncancer Patients.
    Miyamoto T; Fujitani M; Fukuyama H; Hatanaka S; Koizumi Y; Kawabata A
    J Palliat Med; 2019 May; 22(5):532-537. PubMed ID: 30570426
    [No Abstract]   [Full Text] [Related]  

  • 49. Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer.
    Liu X; Sun X; Liu J; Kong P; Chen S; Zhan Y; Xu D
    Transl Oncol; 2015 Aug; 8(4):339-45. PubMed ID: 26310380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of inflammation-based prognostic score on mortality of patients undergoing chemotherapy for far advanced or recurrent unresectable colorectal cancer.
    Ishizuka M; Nagata H; Takagi K; Kubota K
    Ann Surg; 2009 Aug; 250(2):268-72. PubMed ID: 19638907
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Prognostic Value of C-Reactive Protein/Albumin Ratio in Acute Mesenteric Ischemia.
    Kaçer İ; Çağlar A; Akıllı NB
    Am Surg; 2023 May; 89(5):1661-1667. PubMed ID: 35073777
    [TBL] [Abstract][Full Text] [Related]  

  • 52. C-Reactive Protein as a New Prognostic Factor for Survival in Patients With Pancreatic Neuroendocrine Neoplasia.
    Wiese D; Kampe K; Waldmann J; Heverhagen AE; Bartsch DK; Fendrich V
    J Clin Endocrinol Metab; 2016 Mar; 101(3):937-44. PubMed ID: 26678655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Prognostic Value of Systemic Inflammatory Markers in Advanced Renal Cell Carcinoma Patients Treated With Molecular Targeted Therapies.
    Ueda K; Ogasawara N; Yonekura S; Matsunaga Y; Hoshino R; Kurose H; Chikui K; Uemura K; Nakiri M; Nishihara K; Matsuo M; Suekane S; Igawa T
    Anticancer Res; 2020 Mar; 40(3):1739-1745. PubMed ID: 32132082
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pretreatment values of bilirubin and albumin are not prognostic predictors in patients with advanced pancreatic cancer.
    Feng L; Gu S; Wang P; Chen H; Chen Z; Meng Z; Liu L
    Cancer Med; 2018 Dec; 7(12):5943-5951. PubMed ID: 30474926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
    Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
    Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Preoperative C-reactive protein/albumin ratio predicts outcome of surgical papillary renal cell carcinoma.
    Gao J; Agizamhan S; Zhao X; Jiang B; Qin H; Chen M; Guo H
    Future Oncol; 2019 May; 15(13):1459-1468. PubMed ID: 30977386
    [No Abstract]   [Full Text] [Related]  

  • 57. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
    La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
    Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preoperative plasma fibrinogen and C-reactive protein/albumin ratio as prognostic biomarkers for pancreatic carcinoma.
    Chen X; Chen Z; Guo J; Xiu Z; Chen H
    Front Oncol; 2024; 14():1301059. PubMed ID: 38496751
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated inflammatory parameters and inflammation scores are associated with poor prognosis in patients undergoing pulmonary metastasectomy for colorectal cancer.
    Ghanim B; Schweiger T; Jedamzik J; Glueck O; Glogner C; Lang G; Klepetko W; Hoetzenecker K
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):616-23. PubMed ID: 26242317
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison of the Prognostic Value of Systemic Inflammation Response Markers in Small Cell Lung Cancer Patients.
    Zhou T; Zhao Y; Zhao S; Yang Y; Huang Y; Hou X; Zhao H; Zhang L
    J Cancer; 2019; 10(7):1685-1692. PubMed ID: 31205524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.